Pan-cancer association of a centrosome amplification gene expression signature with genomic alterations and clinical outcome.

ABSTRACT: Centrosome amplification (CA) is a common feature of human tumours and a promising target for cancer therapy. However, CA's pan-cancer prevalence, molecular role in tumourigenesis and therapeutic value in the clinical setting are still largely unexplored. Here, we used a transcriptomic signature (CA20) to characterise the landscape of CA-associated gene expression in 9,721 tumours from The Cancer Genome Atlas (TCGA). CA20 is upregulated in cancer and associated with distinct clinical and molecular features of breast cancer, consistently with our experimental CA quantification in patient samples. Moreover, we show that CA20 upregulation is positively associated with genomic instability, alteration of specific chromosomal arms and C>T mutations, and we propose novel molecular players associa

SUBMITTER: de Almeida BP 

PROVIDER: S-EPMC6411098 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature